22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026
22nd Century Group announced that management will participate in the HC Wainwright Conference on September 15, 2026, at the Lotte New York Palace Hotel.
Attending the event will be Chairman and CEO Larry Firestone and CFO Dan Otto, who will be available for meetings with investors.
The company has posted an updated investor presentation to its website to support these discussions.